Mr. Arroche is an associate in Davis Polk's Corporate Department, practicing in the Paris office. His practice focuses on domestic and cross-border mergers and acquisitions and includes representing companies and investment banks in domestic and international capital markets transactions.
- Valeant Pharmaceuticals International $4.565 Billion Term Loan Facility and $1.225 Billion Revolving Credit Facility (2018)
- Underwriters on multiple notes offerings of Société Générale, BPCE and Crédit Agricole
- eDreams in relation to its €175,000,000 super senior revolving credit facility and issuance of €425,000,000 senior secured notes
- Mr. Arroche is a frequent author of legal articles in practice and academic journals.
- Davis Polk since 2017